Therapeutic Areas

Latest News

© photon_photo - © photon_photo - stock.adobe.com.
Therapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial

February 23rd 2024

Phase Ia, open-label, escalating dose study to evaluate the safety and immunogenicity of therapeutic vaccine, TherVacB.

© Aerial Mike - © Aerial Mike - stock.adobe.com.
ImmunityBio Announces Full Accrual of First Two Phases of Cancer Vaccine Trial

February 22nd 2024

© Egor - © Egor - stock.adobe.com
NeuroSense Reports Additional Positive Results from Phase IIb ALS Clinical Trial

February 22nd 2024

© putilov_denis - © putilov_denis - stock.adobe.com
First Subject Dosed in Phase I Clinical Trial of Investigational Protein Degrader for Neurodegenerative Disease

February 21st 2024

© photon_photo - © photon_photo - stock.adobe.com.
First Patient Randomized in Phase II Gene Therapy Trial for Congestive Heart Failure

February 20th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.